Cambridge Innovation Capital

www.cic.vc

CIC is a leading Series A investor in the Cambridge ecosystem focused on life sciences and deep tech companies. They invest in knowledge-intensive businesses at the seed through Series A stages, with later stage funds providing scale-up capital and technical guidance.

Check Size

Not specified

Stages

Seed, Series A, Series B, Growth

Focus Areas

Ai Ml, Biotech, Medtech

Is Cambridge Innovation Capital right for your startup?

Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.

See If You're a Match

Investment Thesis

Cambridge Innovation Capital is driven by a passion for science and its potential to drive change. They believe in matching the objectives of innovators with investor expectations to create companies that contribute to society while generating financial returns. Their core motivation extends beyond commercial value creation to supporting the wider innovation ecosystem and positively impacting society. They are fundamentally driven by people and ideas, seeking to enable pioneers in life sciences and deep tech to create world-leading companies whose unique innovations bring both financial success and global impact.

What Sets Them Apart

Unique proprietary agreement with the University of Cambridge providing privileged access to next-generation investment opportunities and academic IP
Deep network of entrepreneurs, research institutes, and accelerators within Cambridge's world-leading science and technology ecosystem
Team with deep scientific knowledge combined with commercial expertise and technical understanding
Distinguished advisory panel of technical and commercial experts
12 years of experience with £0.6bn AUM and £0.35bn already invested across 45+ portfolio companies
Entrepreneur in Residence (EIR) program matching experienced entrepreneurs with world-class Cambridge researchers
Two accelerators: Start Codon (life sciences) and Deeptech Labs (technology companies)
Access to over £3.2bn in co-investment capital to support portfolio companies